EPIDEMIOLOGICAL PROFILE OF PATIENTS WITH BREAST CANCER TREATED IN THE FEDERAL DISTRICT BETWEEN 2019 AND 2025
DOI:
https://doi.org/10.63330/armv1n8-011Keywords:
Breast cancer, Epidemiology, Federal District, Oncological treatment, MortalityAbstract
Breast cancer is the most prevalent malignant neoplasm among women, being an important public health issue in Brazil and around the world. This study aimed to analyze the epidemiological profile of women diagnosed with breast cancer in the Federal District, considering sociodemographic, clinical and care aspects. This is a quantitative, descriptive and epidemiological approach study, based on secondary data from the InfoSaúde portal of the State Secretariat of Health of the Federal District, for the period from 2020 to 2025. Information on hospitalizations, types of neoplasm, treatments performed and number of deaths were analyzed. Between 2019 and 2025, there were 133 hospitalizations for carcinoma in situ, 835 for invasive malignant neoplasm and 942 for unspecified malignant neoplasm. The age group with the highest incidence varied between 45-49 years and 55-59 years, and the main treatments applied were chemotherapy, hormone therapy and radiotherapy. There was a predominance of deaths in older women and inequality in relation to race/color. The results indicate that, despite advances in diagnosis and treatment, inequalities persist in access to health services. It is concluded that the analysis of the local epidemiological profile is essential to subsidize public policies, screening programs and comprehensive care strategies, aiming to reduce morbidity and mortality and improve the quality of life of patients.
References
BALABRAM, Débora; TURRA, Cassio M.; GOBBI, Helenice. Association between age and survival in a cohort of Brazilian patients with operable breast cancer. Cadernos de Saúde Pública, v. 31, p. 1732–1742, 2015. Disponível em: https://doi.org/10.1590/0102-311X00114214. Acesso em: 21 out. 2025.
BESSA, Jordana de Faria et al. An update on the status of breast cancer screening in Brazil after the covid-19 pandemic. Revista de Saúde Pública, v. 56, p. 88, 2022. Disponível em: https://pmc.ncbi.nlm.nih.gov/articles/PMC9550160/. Acesso em: 20 set. 2025.
CARDOSO, F.; SENKUS, E.; COSTA, A.; PAPADOPOULOS, E.; AAPRO, M.; ANDRÉ, F.; …; WINER, E. Breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology, v. 30, n. 5, p. 844–870, 2019. Disponível em: https://doi.org/10.1093/annonc/mdz173. Acesso em: 20 out. 2025.
COSTA, Thalita da Luz et al. Impacts of Sociodemographic Factors, Screening, and Organization of Health Services on Breast Cancer Mortality in Brazil: An Ecological Study of 20 Years. International Journal of Breast Cancer, [S.l.], v. 2023, art. 6665725, 2023. Disponível em: https://doi.org/10.1155/2023/6665725. Acesso em: 20 set. 2025.
DA SILVA, Jessé Lopes; THULER, Luiz Claudio Santos; DE MELO, Andréia Cristina. Breast cancer patterns by age groups in Brazil: insights from population-based registries data. BMC Cancer, v. 25, n. 1, p. 18, 2025. Disponível em: https://doi.org/10.1186/s12885-024-13381-5. Acesso em: 20 out. 2025.
EARLY BREAST CANCER TRIALISTS' COLLABORATIVE GROUP. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. The Lancet, v. 365, n. 9472, p. 1687–1717, 2015. Disponível em: https://doi.org/10.1016/S0140-6736(05)66544-0. Acesso em: 20 out. 2025.
FERREIRA, V. N., et al. Perfil epidemiológico das neoplasias malignas da mama em mulheres brasileiras entre 2010 e 2018. Revista de Enfermagem e Saúde Coletiva, v. 5, n. 1, p. 33–41, 2020.
ROGERS, Jane E.; TRAIL, Allison; AJANI, Jaffer A. Localized Gastroesophageal Cancers: Can We Shift the Current Treatment Paradigms?. Journal of the National Comprehensive Cancer Network, v. 20, n. 2, p. 100-101, 2022., W. J.; ANDERSON, B. O.; BALASSANIAN, R.; BLAIR, S. L.; BURSTEIN, H. J.; CYR, A.; …; YEE, G. C. Breast Cancer, Version 4.2022. Disponível em: https://doi.org/10.6004/jnccn.2022.0013. Acesso em: 20 out. 2025.
GRIMM, L. J.; RAHBAR, H.; ABDELMALAK, M.; HALL, A. H.; RYSER, M. D. Ductal carcinoma in situ: State-of-the-art review. Radiology, v. 302, n. 2, p. 246–255, 2022. Disponível em: https://doi.org/10.1148/radiol.211839. Acesso em: 20 out. 2025.
HAVILAND, J. S.; OWEN, J. R.; DEWAR, J. A.; AGRAWAL, R. K.; BARRETT, J.; BARRETT-LEE, P. J.; …; YARNOLD, J. R. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results. The Lancet Oncology, v. 14, n. 11, p. 1086–1094, 2013. Disponível em: https://doi.org/10.1016/S1470-2045(13)70386-3. Acesso em: 20 out. 2025.
INSTITUTO NACIONAL DE CÂNCER (INCA). Controle do câncer de mama no Brasil: dados e números — 2024. Rio de Janeiro: INCA, 2024. Disponível em: https://ninho.inca.gov.br/jspui/handle/123456789/17002 (Tabela 2). Acesso em: 21 out. 2025.
INSTITUTO NACIONAL DE CÂNCER (INCA). Estimativa 2023: Incidência e Mortalidade por Câncer no Brasil. Rio de Janeiro: INCA, 2023a. Disponível em: https://www.gov.br/inca/pt-br/assuntos/cancer/numeros. Acesso em: 21 out. 2025.
INSTITUTO NACIONAL DE CÂNCER (INCA). Mortalidade por Câncer de Mama no Brasil. Rio de Janeiro: INCA, 2023b. Disponível em: https://www.gov.br/inca/pt-br/assuntos/gestor-e-profissional-de-saude/controle-do-cancer-de-mama/dados-e-numeros/mortalidade. Acesso em: 21 out. 2025.
INSTITUTO NACIONAL DE CÂNCER (INCA). Ministério da Saúde e INCA apresentam publicação com dados atualizados sobre câncer de mama no Brasil. Brasília: Ministério da Saúde, 2025. Disponível em: https://www.gov.br/saude/pt-br/assuntos/noticias/2025/outubro/ministerio-da-saude-e-inca-apresentam-publicacao-com-dados-atualizados-sobre-cancer-de-mama-no-brasil. Acesso em: 21 out. 2025.
SANTOS TDS, GONÇALVES CA, CUNHA CPD, MILHOMEM JP, SILVA KMD, COSTA BTD, PIANTOLO RG, FERNANDES RJC, SILVA YMD, GUIMARÃES RM. Temporal trend of breast cancer burden among younger and older Brazilian women, 1990-2019. Rev Bras Epidemiol. 2025 Mar 3;28:e250006. doi: 10.1590/1980-549720250006. PMID: 40053004; PMCID: PMC11884820. Disponível em: https://pubmed.ncbi.nlm.nih.gov/40053004/. Acesso em 20 set. 2025.
INSTITUTO NACIONAL DE CÂNCER (INCA) JOSÉ ALENCAR GOMES DA SILVA. Estimativa 2023: incidência de câncer no Brasil. Rio de Janeiro: INCA, 2023. Disponível em: https://www.inca.gov.br/es/node/6104. Acesso em: 20 set. 2025.
NADER-MARTA, G. 2023 Year in review: Early breast cancer. PubMed Central, 2024. Disponível em: https://pubmed.ncbi.nlm.nih.gov/38422625/. Acesso em: 20 out. 2025.
SANTOS, M. O.; SOUZA, D. L. B. Epidemiologia do câncer de mama no Brasil e tendências de mortalidade: uma revisão de literatura. Revista Brasileira de Cancerologia, 67(3), e-031141, 2021. Disponível em: https://doi.org/10.32635/2176-9745.RBC.2023v69n1.3700. Acesso em: 20 out. 2025.
VALE, D. B. et al. Breast cancer mortality rates trends by race in São Paulo, Brazil. European Journal of Public Health, v. 30, n. Supplement_5, p. ckaa166.1162, 2020. Disponível em: https://academic.oup.com/eurpub/article/30/Supplement_5/ckaa166.1162/5916020. Acesso em: 20 set. 2025.
WORLD HEALTH ORGANIZATION. Breast cancer. OMS, 14 ago. 2025. Disponível em: https://www.who.int/news-room/fact-sheets/detail/breast-cancer. Acesso em: 20 set. 2025.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
